ARCHIVES

News Analysis by Keith Baggerly: Duke Trials Went On Despite FDA Statements

This article is from The Cancer Letter archive.

Vol. 38 No. 04 | January 27, 2012

Download PDF Visit The Full Archive

Related Articles

NCI To Recomplete CIDAC Contracts

September 23, 1977

Two-Week Break Balances RT Palliation, Side Effects

February 26, 2010

An Impromptu Group Proposes Standards For Publication Of Genomics Research

October 1, 2010

FDA Approves Evista for Breast Cancer Risk Reduction.

September 14, 2007

Shubick Committee Support New System for NCU Review, Action On Chemicals

November 14, 1975

NCI Advisors Approve Plans To Continue Current Research Programs.

July 3, 2008